{"id":9339,"date":"2022-05-04T15:45:00","date_gmt":"2022-05-04T13:45:00","guid":{"rendered":"https:\/\/irlab.se\/mfn_news\/irlab-bjuder-in-till-presentation-av-delarsrapport-for-forsta-kvartalet-2022\/"},"modified":"2022-05-04T15:45:00","modified_gmt":"2022-05-04T13:45:00","slug":"irlab-bjuder-in-till-presentation-av-delarsrapport-for-forsta-kvartalet-2022","status":"publish","type":"mfn_news","link":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-bjuder-in-till-presentation-av-delarsrapport-for-forsta-kvartalet-2022\/","title":{"rendered":"IRLAB bjuder in till presentation av del\u00e5rsrapport f\u00f6r f\u00f6rsta kvartalet 2022"},"content":{"rendered":"

[mfn_before_post]<\/p>\n

\n

IRLAB Therapeutics AB (publ) meddelade idag att bolaget h\u00e5ller en telefonkonferens i anslutning till publiceringen av del\u00e5rsrapporten f\u00f6r f\u00f6rsta kvartalet, januari-mars, 2022. Rapporten kommer att publiceras p\u00e5 onsdag den 11 maj kl. 07.45 CET.<\/strong><\/p>\n<\/div>\n

\n

Telefonkonferensen kommer att h\u00e5llas kl. 10.30 CET den 11 maj 2022 d\u00e4r VD Nicholas Waters och CFO Viktor Siewertz kommer att kommentera del\u00e5rsrapporten f\u00f6r f\u00f6rsta kvartalet, januari-mars, 2022. Presentationen kommer att h\u00e5llas p\u00e5 engelska och f\u00f6ljs av m\u00f6jligheten att st\u00e4lla fr\u00e5gor.<\/p>\n

De som vill delta i telefonkonferensen ringer in p\u00e5:
SE +46 850 558 369
UK +44 333 300 9260
US +1 631 913 1422<\/p>\n

Det \u00e4r ocks\u00e5 m\u00f6jligt att f\u00f6lja telefonkonferensen via l\u00e4nk: https:\/\/tv.streamfabriken.com\/irlab-q1-2022<\/a><\/p>\n

Presentationsmaterialet kommer att vara p\u00e5 engelska och finnas tillg\u00e4ngligt i samband med telefonkonferensen p\u00e5 www.irlab.se<\/a> d\u00e4r \u00e4ven den inspelade versionen av presentationen kommer att finnas att tillg\u00e5 i efterhand.<\/p>\n<\/div>\n

\n

F\u00f6r mer information<\/strong><\/p>\n

\n

Viktor Siewertz, CFO
Tel: +46 727 10 70 70
E-post:\u00a0viktor.siewertz@irlab.se<\/a><\/p>\n<\/div>\n

\n

Om IRLAB<\/strong><\/p>\n

\n

IRLAB uppt\u00e4cker och utvecklar nya l\u00e4kemedel f\u00f6r behandling av Parkinsons sjukdom och andra sjukdomar i hj\u00e4rnan. Bolagets l\u00e4ngst framskridna l\u00e4kemedelskandidater, mesdopetam (IRL790) och pirepemat (IRL752) \u00e4r b\u00e5da i Fas IIb och \u00e4r designade f\u00f6r att behandla n\u00e5gra av de sv\u00e5raste symtomen relaterade till Parkinsons sjukdom. Under 2021 ingick IRLAB ett exklusivt och globalt licensavtal med Ipsen f\u00f6r utveckling och marknadsf\u00f6ring av mesdopetam.
\u00a0
Genom den egenutvecklade forskningsplattformen ISP (Integrative Screening Process) har IRLAB uppt\u00e4ckt och utvecklat alla sina projekt och forts\u00e4tter att uppt\u00e4cka innovativa l\u00e4kemedelskandidater f\u00f6r behandling av sjukdomar relaterade till det centrala nervsystemet. F\u00f6rutom IRLAB:s starka kliniska pipeline driver IRLAB ett flertal prekliniska program d\u00e4r IRL942 och IRL757 \u00e4r i utveckling f\u00f6r Fas I. IRLAB \u00e4r noterat p\u00e5 Nasdaq Stockholms huvudlista. Mer information p\u00e5\u00a0www.irlab.se.<\/a><\/p>\n<\/div>\n

\n

Bifogade filer<\/strong><\/p>\n

\n

IRLAB bjuder in till presentation av del\u00e5rsrapport f\u00f6r f\u00f6rsta kvartalet 2022<\/a><\/p>\n<\/div>\n

[mfn_after_post]<\/p>\n","protected":false},"excerpt":{"rendered":"

IRLAB Therapeutics AB (publ) meddelade idag att bolaget h\u00e5ller en telefonkonferens i anslutning till publiceringen av del\u00e5rsrapporten f\u00f6r f\u00f6rsta kvartalet, januari-mars, 2022. Rapporten kommer att publiceras p\u00e5 onsdag den 11 maj kl. 07.45 CET.<\/p>\n","protected":false},"template":"","class_list":["post-9339","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-other_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"\nIRLAB bjuder in till presentation av del\u00e5rsrapport f\u00f6r f\u00f6rsta kvartalet 2022 - IRLAB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/irlab.se\/mfn_news\/irlab-bjuder-in-till-presentation-av-delarsrapport-for-forsta-kvartalet-2022\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IRLAB bjuder in till presentation av del\u00e5rsrapport f\u00f6r f\u00f6rsta kvartalet 2022 - IRLAB\" \/>\n<meta property=\"og:description\" content=\"IRLAB Therapeutics AB (publ) meddelade idag att bolaget h\u00e5ller en telefonkonferens i anslutning till publiceringen av del\u00e5rsrapporten f\u00f6r f\u00f6rsta kvartalet, januari-mars, 2022. Rapporten kommer att publiceras p\u00e5 onsdag den 11 maj kl. 07.45 CET.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/irlab.se\/mfn_news\/irlab-bjuder-in-till-presentation-av-delarsrapport-for-forsta-kvartalet-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"IRLAB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/irlab.se\/mfn_news\/irlab-bjuder-in-till-presentation-av-delarsrapport-for-forsta-kvartalet-2022\/\",\"url\":\"https:\/\/irlab.se\/mfn_news\/irlab-bjuder-in-till-presentation-av-delarsrapport-for-forsta-kvartalet-2022\/\",\"name\":\"IRLAB bjuder in till presentation av del\u00e5rsrapport f\u00f6r f\u00f6rsta kvartalet 2022 - IRLAB\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/#website\"},\"datePublished\":\"2022-05-04T13:45:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/irlab.se\/mfn_news\/irlab-bjuder-in-till-presentation-av-delarsrapport-for-forsta-kvartalet-2022\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/irlab.se\/mfn_news\/irlab-bjuder-in-till-presentation-av-delarsrapport-for-forsta-kvartalet-2022\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/irlab.se\/mfn_news\/irlab-bjuder-in-till-presentation-av-delarsrapport-for-forsta-kvartalet-2022\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/irlab.se\/sv\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\/\/irlab.se\/sv\/pressmeddelanden\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"IRLAB bjuder in till presentation av del\u00e5rsrapport f\u00f6r f\u00f6rsta kvartalet 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/irlab.se\/#website\",\"url\":\"https:\/\/irlab.se\/\",\"name\":\"Irlab\",\"description\":\"Novel treatments for Parkinson's disease\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/irlab.se\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IRLAB bjuder in till presentation av del\u00e5rsrapport f\u00f6r f\u00f6rsta kvartalet 2022 - IRLAB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/irlab.se\/mfn_news\/irlab-bjuder-in-till-presentation-av-delarsrapport-for-forsta-kvartalet-2022\/","og_locale":"sv_SE","og_type":"article","og_title":"IRLAB bjuder in till presentation av del\u00e5rsrapport f\u00f6r f\u00f6rsta kvartalet 2022 - IRLAB","og_description":"IRLAB Therapeutics AB (publ) meddelade idag att bolaget h\u00e5ller en telefonkonferens i anslutning till publiceringen av del\u00e5rsrapporten f\u00f6r f\u00f6rsta kvartalet, januari-mars, 2022. Rapporten kommer att publiceras p\u00e5 onsdag den 11 maj kl. 07.45 CET.","og_url":"https:\/\/irlab.se\/mfn_news\/irlab-bjuder-in-till-presentation-av-delarsrapport-for-forsta-kvartalet-2022\/","og_site_name":"IRLAB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"2 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/irlab.se\/mfn_news\/irlab-bjuder-in-till-presentation-av-delarsrapport-for-forsta-kvartalet-2022\/","url":"https:\/\/irlab.se\/mfn_news\/irlab-bjuder-in-till-presentation-av-delarsrapport-for-forsta-kvartalet-2022\/","name":"IRLAB bjuder in till presentation av del\u00e5rsrapport f\u00f6r f\u00f6rsta kvartalet 2022 - IRLAB","isPartOf":{"@id":"https:\/\/irlab.se\/#website"},"datePublished":"2022-05-04T13:45:00+00:00","breadcrumb":{"@id":"https:\/\/irlab.se\/mfn_news\/irlab-bjuder-in-till-presentation-av-delarsrapport-for-forsta-kvartalet-2022\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/irlab.se\/mfn_news\/irlab-bjuder-in-till-presentation-av-delarsrapport-for-forsta-kvartalet-2022\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/irlab.se\/mfn_news\/irlab-bjuder-in-till-presentation-av-delarsrapport-for-forsta-kvartalet-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/irlab.se\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/irlab.se\/sv\/pressmeddelanden\/"},{"@type":"ListItem","position":3,"name":"IRLAB bjuder in till presentation av del\u00e5rsrapport f\u00f6r f\u00f6rsta kvartalet 2022"}]},{"@type":"WebSite","@id":"https:\/\/irlab.se\/#website","url":"https:\/\/irlab.se\/","name":"Irlab","description":"Novel treatments for Parkinson's disease","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/irlab.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/mfn_news\/9339","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/media?parent=9339"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}